Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Farooqui, Saleem
119  Ergebnisse:
Personensuche X
?
1

Integrated Safety Update of Abrocitinib in 3802 Patients wi..:

Simpson, Eric L. ; Silverberg, Jonathan I. ; Nosbaum, Audrey...
American Journal of Clinical Dermatology.  25 (2024)  4 - p. 639-654 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Long-Term Efficacy of Abrocitinib in Adolescents and Adults..:

Paller, Amy ; Cork, Michael ; Flohr, Carsten...
SKIN The Journal of Cutaneous Medicine.  8 (2024)  1 - p. s329 , 2024
Link: https://doi.org/10.25251..
 
?
3

530 - Treatment efficacy in patients with moderate-to-sever..:

Gooderham, Melinda J ; Weidinger, Stephan ; Simpson, Eric L...
British Journal of Dermatology.  190 (2024)  Supplement_2 - p. ii32-ii33 , 2024
Link: https://doi.org/10.1093/..
 
?
4

44115 Integrated Safety Analysis of Abrocitinib in 3802 Pat..:

Simpson, Eric L. ; Silverberg, Jonathan I. ; Nosbaum, Audrey...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB58 , 2023
Link: https://doi.org/10.1016/..
 
?
5

44095 Response to Abrocitinib up to Week 96 According to Sh..:

Silverberg, Jonathan I. ; Reich, Kristian ; de Bruin-Weller, Marjolein...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB218 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Safety of Abrocitinib in 3582 Patients With Moderate-to-Sev..:

Simpson, Eric L. ; Silverberg, Johnathan ; Nosbaum, Audrey...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  2 - p. s150 , 2023
Link: https://doi.org/10.25251..
 
?
7

Abrocitinib efficacy and safety in patients with moderate‐t..:

Reich, Kristian ; Silverberg, Jonathan I. ; Papp, Kim A....
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  10 - p. 2056-2066 , 2023
Link: https://doi.org/10.1111/..
 
?
8

330 Safety of abrocitinib in 3582 patients with moderate-to..:

Simpson, Eric L ; Silverberg, Jonathan I ; Nosbaum, Audrey...
British Journal of Dermatology.  188 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
9

44180 Influence of Baseline Disease Severity Defined by Inv..:

Gooderham, Melinda ; Simpson, Eric ; Geng, Bob...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB181 , 2023
Link: https://doi.org/10.1016/..
 
?
10

P81 Long-term efficacy of abrocitinib in adolescents and ad..:

Paller, Amy S ; Cork, Michael J ; Flohr, Carsten...
British Journal of Dermatology.  188 (2023)  Supplement_4 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
11

44042 Abrocitinib Long-Term Efficacy for up to 96 Weeks in ..:

Reich, Kristian ; Silverberg, Jonathan I. ; de Bruin-Weller, Marjolein...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB116 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Contributors:

, In: Advanced Biofuel Technologies,
Awasthi, Deepika ; Bardhan, Sougata ; Bhaskar, Thallada... - p. xi-xiii , 2022
Link: https://doi.org/10.1016/..
 
?
13

Progress and trends in renewable jet fuels:

, In: Advanced Biofuel Technologies,
Farooqui, Saleem A. ; Sinha, Anil K. ; Ray, Anjan - p. 333-364 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Abrocitinib monotherapy in Investigator's Global Assessment..:

Blauvelt, Andrew ; Boguniewicz, Mark ; Brunner, Patrick M....
Journal of Dermatological Treatment.  33 (2022)  5 - p. 2605-2613 , 2022
Link: https://doi.org/10.1080/..
 
?
15

27489 Depth of response to abrocitinib in adults with moder..:

Ständer, Sonja ; Bhatia, Neal ; Gooderham, Melinda J....
Journal of the American Academy of Dermatology.  85 (2021)  3 - p. AB148 , 2021
Link: https://doi.org/10.1016/..
 
1-15